Bill Text: NY S07912 | 2013-2014 | General Assembly | Introduced


Bill Title: Relates to insurance coverage for substance use disorder; requires health plans to use a health care provider who specializes in behavioral health or substance use disorder treatment to supervise and oversee the medical management decisions relating to substance abuse treatment.

Spectrum: Moderate Partisan Bill (Republican 22-7)

Status: (Passed) 2014-06-23 - SIGNED CHAP.41 [S07912 Detail]

Download: New_York-2013-S07912-Introduced.html
                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
           S. 7912                                                 A. 10164
                             S E N A T E - A S S E M B L Y
                                     June 17, 2014
                                      ___________
       IN SENATE -- Introduced by Sens. SEWARD, HANNON, MARTINS, RITCHIE -- (at
         request  of  the Governor) -- read twice and ordered printed, and when
         printed to be committed to the Committee on Rules
       IN ASSEMBLY -- Introduced by COMMITTEE ON RULES -- (at request of M.  of
         A.  Cusick)  -- (at request of the Governor) -- read once and referred
         to the Committee on Insurance
       AN ACT to amend the insurance law and the public health law, in relation
         to requiring health insurance  coverage  for  substance  use  disorder
         treatment  services  and creating a workgroup to study and make recom-
         mendations
         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section  1.    Subsection  (i) of section 3216 of the insurance law is
    2  amended by adding two new paragraphs 30 and 31 to read as follows:
    3    (30)(A) EVERY POLICY THAT PROVIDES HOSPITAL, MAJOR MEDICAL OR  SIMILAR
    4  COMPREHENSIVE COVERAGE MUST PROVIDE INPATIENT COVERAGE FOR THE DIAGNOSIS
    5  AND  TREATMENT  OF  SUBSTANCE USE DISORDER, INCLUDING DETOXIFICATION AND
    6  REHABILITATION  SERVICES.  SUCH  COVERAGE  SHALL  NOT  APPLY   FINANCIAL
    7  REQUIREMENTS  OR TREATMENT LIMITATIONS TO INPATIENT SUBSTANCE USE DISOR-
    8  DER BENEFITS THAT ARE MORE RESTRICTIVE THAN  THE  PREDOMINANT  FINANCIAL
    9  REQUIREMENTS  AND  TREATMENT  LIMITATIONS  APPLIED  TO SUBSTANTIALLY ALL
   10  MEDICAL AND SURGICAL BENEFITS COVERED BY  THE  POLICY.    FURTHER,  SUCH
   11  COVERAGE  SHALL  BE  PROVIDED CONSISTENT WITH THE FEDERAL PAUL WELLSTONE
   12  AND PETE DOMENICI MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT OF  2008
   13  (29 U.S.C. S 1185A).
   14    (B)  COVERAGE  PROVIDED UNDER THIS PARAGRAPH MAY BE LIMITED TO FACILI-
   15  TIES IN NEW YORK STATE WHICH ARE CERTIFIED BY THE OFFICE  OF  ALCOHOLISM
   16  AND  SUBSTANCE  ABUSE  SERVICES AND, IN OTHER STATES, TO THOSE WHICH ARE
   17  ACCREDITED BY THE JOINT COMMISSION AS ALCOHOLISM,  SUBSTANCE  ABUSE,  OR
   18  CHEMICAL DEPENDENCE TREATMENT PROGRAMS.
   19    (C)  COVERAGE  PROVIDED  UNDER THIS PARAGRAPH MAY BE SUBJECT TO ANNUAL
   20  DEDUCTIBLES AND CO-INSURANCE AS DEEMED APPROPRIATE BY THE SUPERINTENDENT
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD12108-01-4
       S. 7912                             2                           A. 10164
    1  AND THAT ARE CONSISTENT WITH THOSE IMPOSED ON OTHER  BENEFITS  WITHIN  A
    2  GIVEN POLICY.
    3    (31)  (A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR
    4  COMPREHENSIVE-TYPE COVERAGE MUST PROVIDE  OUTPATIENT  COVERAGE  FOR  THE
    5  DIAGNOSIS AND TREATMENT OF SUBSTANCE USE DISORDER, INCLUDING DETOXIFICA-
    6  TION  AND  REHABILITATION SERVICES. SUCH COVERAGE SHALL NOT APPLY FINAN-
    7  CIAL REQUIREMENTS OR TREATMENT LIMITATIONS TO OUTPATIENT  SUBSTANCE  USE
    8  DISORDER  BENEFITS THAT ARE MORE RESTRICTIVE THAN THE PREDOMINANT FINAN-
    9  CIAL REQUIREMENTS AND TREATMENT LIMITATIONS APPLIED TO SUBSTANTIALLY ALL
   10  MEDICAL AND SURGICAL BENEFITS  COVERED  BY  THE  POLICY.  FURTHER,  SUCH
   11  COVERAGE  SHALL  BE  PROVIDED CONSISTENT WITH THE FEDERAL PAUL WELLSTONE
   12  AND PETE DOMENICI MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT OF  2008
   13  (29 U.S.C. S 1185A).
   14    (B)  COVERAGE UNDER THIS PARAGRAPH MAY BE LIMITED TO FACILITIES IN NEW
   15  YORK STATE CERTIFIED BY THE OFFICE OF  ALCOHOLISM  AND  SUBSTANCE  ABUSE
   16  SERVICES  OR  LICENSED BY SUCH OFFICE AS OUTPATIENT CLINICS OR MEDICALLY
   17  SUPERVISED AMBULATORY SUBSTANCE ABUSE PROGRAMS AND, IN OTHER STATES,  TO
   18  THOSE  WHICH  ARE  ACCREDITED  BY  THE JOINT COMMISSION AS ALCOHOLISM OR
   19  CHEMICAL DEPENDENCE SUBSTANCE ABUSE TREATMENT PROGRAMS.
   20    (C) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE  SUBJECT  TO  ANNUAL
   21  DEDUCTIBLES AND CO-INSURANCE AS DEEMED APPROPRIATE BY THE SUPERINTENDENT
   22  AND  THAT  ARE  CONSISTENT WITH THOSE IMPOSED ON OTHER BENEFITS WITHIN A
   23  GIVEN POLICY.
   24    (D) A POLICY PROVIDING COVERAGE FOR SUBSTANCE  USE  DISORDER  SERVICES
   25  PURSUANT  TO THIS PARAGRAPH SHALL PROVIDE UP TO TWENTY OUTPATIENT VISITS
   26  PER POLICY OR CALENDAR YEAR TO  AN  INDIVIDUAL  WHO  IDENTIFIES  HIM  OR
   27  HERSELF  AS  A  FAMILY  MEMBER  OF A PERSON SUFFERING FROM SUBSTANCE USE
   28  DISORDER AND WHO SEEKS TREATMENT AS A FAMILY  MEMBER  WHO  IS  OTHERWISE
   29  COVERED  BY THE APPLICABLE POLICY PURSUANT TO THIS PARAGRAPH. THE COVER-
   30  AGE REQUIRED BY THIS PARAGRAPH  SHALL  INCLUDE  TREATMENT  AS  A  FAMILY
   31  MEMBER  PURSUANT TO SUCH FAMILY MEMBER'S OWN POLICY PROVIDED SUCH FAMILY
   32  MEMBER:
   33    (I) DOES NOT EXCEED THE ALLOWABLE NUMBER OF FAMILY VISITS PROVIDED  BY
   34  THE APPLICABLE POLICY PURSUANT TO THIS PARAGRAPH; AND
   35    (II)  IS OTHERWISE ENTITLED TO COVERAGE PURSUANT TO THIS PARAGRAPH AND
   36  SUCH FAMILY MEMBER'S APPLICABLE POLICY.
   37    S 2. Paragraphs 6 and 7 of subsection  (l)  of  section  3221  of  the
   38  insurance law, paragraph 6 as amended by chapter 558 of the laws of 1999
   39  and  paragraph  7  as  amended  by  chapter 565 of the laws of 2000, are
   40  amended to read as follows:
   41    (6) (A) Every [insurer delivering a group or school blanket policy  or
   42  issuing  a  group  or school blanket policy for delivery, in this state,
   43  which] POLICY THAT  provides  [coverage  for  inpatient  hospital  care]
   44  HOSPITAL,  MAJOR  MEDICAL  OR  SIMILAR COMPREHENSIVE COVERAGE must [make
   45  available and, if requested  by  the  policyholder,]  provide  INPATIENT
   46  coverage for the diagnosis and treatment of [chemical abuse and chemical
   47  dependence,  however defined in such policy, provided, however, that the
   48  term chemical abuse shall mean and include alcohol and  substance  abuse
   49  and  chemical dependence shall mean and include alcoholism and substance
   50  dependence, however defined in such policy. Written notice of the avail-
   51  ability of such coverage shall be delivered to the policyholder prior to
   52  inception of such group policy and annually thereafter, except that this
   53  notice shall not be required where a policy covers two hundred  or  more
   54  employees  or  where the benefit structure was the subject of collective
   55  bargaining affecting persons who are employed in more than one state.
   56    (B) Such coverage shall be at least equal to the following:
       S. 7912                             3                           A. 10164
    1    (i) with respect to benefits for detoxification as  a  consequence  of
    2  chemical  dependence,  inpatient benefits in a hospital or a detoxifica-
    3  tion facility may not be limited to  less  than  seven  days  of  active
    4  treatment in any calendar year; and
    5    (ii)  with respect to benefits for rehabilitation services, such bene-
    6  fits may not be limited to less than thirty days of  inpatient  care  in
    7  any calendar year.] SUBSTANCE USE DISORDER, INCLUDING DETOXIFICATION AND
    8  REHABILITATION   SERVICES.  SUCH  COVERAGE  SHALL  NOT  APPLY  FINANCIAL
    9  REQUIREMENTS OR TREATMENT LIMITATIONS TO INPATIENT SUBSTANCE USE  DISOR-
   10  DER  BENEFITS  THAT  ARE MORE RESTRICTIVE THAN THE PREDOMINANT FINANCIAL
   11  REQUIREMENTS AND TREATMENT  LIMITATIONS  APPLIED  TO  SUBSTANTIALLY  ALL
   12  MEDICAL  AND  SURGICAL  BENEFITS  COVERED BY THE POLICY.   FURTHER, SUCH
   13  COVERAGE SHALL BE PROVIDED CONSISTENT WITH THE  FEDERAL  PAUL  WELLSTONE
   14  AND  PETE DOMENICI MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT OF 2008
   15  (29 U.S.C. S 1185A).
   16    [(C) Such coverage] (B) COVERAGE PROVIDED UNDER THIS PARAGRAPH may  be
   17  limited  to  facilities  in  New  York  state which are certified by the
   18  office of alcoholism and substance abuse services and, in other  states,
   19  to  those which are accredited by the joint commission [on accreditation
   20  of hospitals] as alcoholism,  substance  abuse  or  chemical  dependence
   21  treatment programs.
   22    [(D) Such coverage shall be made available at the inception of all new
   23  policies  and with respect to all other policies at any anniversary date
   24  of the policy subject to evidence of insurability.
   25    (E) Such coverage] (C) COVERAGE PROVIDED UNDER THIS PARAGRAPH  may  be
   26  subject to annual deductibles and co-insurance as [may be] deemed appro-
   27  priate  by the superintendent and THAT are consistent with those imposed
   28  on other benefits within a given policy. [Further,  each  insurer  shall
   29  report to the superintendent each year the number of contract holders to
   30  whom  it  has  issued  policies  for the inpatient treatment of chemical
   31  dependence, and the approximate number of persons covered by such  poli-
   32  cies.
   33    (F)  Such  coverage  shall not replace, restrict or eliminate existing
   34  coverage provided by the policy.]
   35    (7) (A) Every [insurer delivering a group or school blanket policy  or
   36  issuing  a  group  or  school  blanket policy for delivery in this state
   37  which] POLICY THAT  provides  [coverage  for  inpatient  hospital  care]
   38  MEDICAL,  MAJOR  MEDICAL  OR  SIMILAR  COMPREHENSIVE-TYPE  COVERAGE must
   39  provide OUTPATIENT coverage for [at least sixty outpatient visits in any
   40  calendar year for] the diagnosis and treatment of  [chemical  dependence
   41  of  which  up  to  twenty  may  be  for family members, except that this
   42  provision shall not apply to a policy which covers persons  employed  in
   43  more than one state or the benefit structure of which was the subject of
   44  collective  bargaining  affecting  persons who are employed in more than
   45  one state.] SUBSTANCE USE DISORDER, INCLUDING DETOXIFICATION  AND  REHA-
   46  BILITATION  SERVICES.  SUCH  COVERAGE SHALL NOT APPLY FINANCIAL REQUIRE-
   47  MENTS OR TREATMENT LIMITATIONS  TO  OUTPATIENT  SUBSTANCE  USE  DISORDER
   48  BENEFITS  THAT  ARE  MORE  RESTRICTIVE  THAN  THE  PREDOMINANT FINANCIAL
   49  REQUIREMENTS AND TREATMENT  LIMITATIONS  APPLIED  TO  SUBSTANTIALLY  ALL
   50  MEDICAL  AND  SURGICAL  BENEFITS  COVERED BY THE POLICY.   FURTHER, SUCH
   51  COVERAGE SHALL BE PROVIDED CONSISTENT WITH THE  FEDERAL  PAUL  WELLSTONE
   52  AND  PETE DOMENICI MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT OF 2008
   53  (29 U.S.C. S 1185A).
   54    [Such coverage]  (B) COVERAGE UNDER THIS PARAGRAPH may be  limited  to
   55  facilities  in  New York state certified by the office of alcoholism and
   56  substance abuse services or licensed by such office as outpatient  clin-
       S. 7912                             4                           A. 10164
    1  ics  or medically supervised ambulatory substance abuse programs and, in
    2  other states, to those which are accredited by the joint commission  [on
    3  accreditation  of hospitals] as alcoholism or chemical dependence treat-
    4  ment programs.
    5    [Such  coverage]  (C)  COVERAGE  PROVIDED  UNDER THIS PARAGRAPH may be
    6  subject to annual deductibles and co-insurance as [may be] deemed appro-
    7  priate by the superintendent and THAT are consistent with those  imposed
    8  on  other  benefits  within  a  given  policy.  [Such coverage shall not
    9  replace, restrict, or eliminate existing coverage provided by the  poli-
   10  cy.  Except  as otherwise provided in the applicable policy or contract,
   11  no insurer delivering a group or school  blanket  policy  or  issuing  a
   12  group  or  school  blanket  policy  providing coverage for alcoholism or
   13  substance abuse services pursuant to this section shall deny coverage to
   14  a family member]
   15    (D) A POLICY PROVIDING COVERAGE FOR SUBSTANCE  USE  DISORDER  SERVICES
   16  PURSUANT  TO THIS PARAGRAPH SHALL PROVIDE UP TO TWENTY OUTPATIENT VISITS
   17  PER POLICY OR CALENDAR YEAR TO AN INDIVIDUAL who  identifies  [themself]
   18  HIM  OR  HERSELF  as  a  family  member  of a person suffering from [the
   19  disease of alcoholism, substance abuse or chemical dependency] SUBSTANCE
   20  USE DISORDER and who seeks treatment as a family member who is otherwise
   21  covered  by  the  applicable  policy  [or  contract]  pursuant  to  this
   22  [section]  PARAGRAPH.    The  coverage  required by this paragraph shall
   23  include treatment as a family member pursuant to such family  [members']
   24  MEMBER'S own policy [or contract] provided such family member:
   25    (i)  does not exceed the allowable number of family visits provided by
   26  the applicable policy [or contract] pursuant to  this  [section,]  PARA-
   27  GRAPH; and
   28    (ii)  is  otherwise  entitled  to  coverage pursuant to this [section]
   29  PARAGRAPH and such family  [members']  MEMBER'S  applicable  policy  [or
   30  contract].
   31    S  3.  Subsections  (k)  and (l) of section 4303 of the insurance law,
   32  subsection (k) as amended by  chapter  558  of  the  laws  of  1999  and
   33  subsection  (l)  as  amended  by  chapter  565  of the laws of 2000, are
   34  amended to read as follows:
   35    (k) [A hospital service corporation or a  health  service  corporation
   36  which]  (1)  EVERY  CONTRACT  THAT  provides [group, group remittance or
   37  school blanket coverage for inpatient  hospital  care]  HOSPITAL,  MAJOR
   38  MEDICAL  OR  SIMILAR  COMPREHENSIVE COVERAGE must [make available and if
   39  requested by the contract holder] provide  INPATIENT  coverage  for  the
   40  diagnosis  and  treatment  of  [chemical  abuse and chemical dependence,
   41  however defined in such policy, provided, however, that the term  chemi-
   42  cal  abuse shall mean and include alcohol and substance abuse and chemi-
   43  cal dependence shall mean and include alcoholism and  substance  depend-
   44  ence,  however  defined in such policy, except that this provision shall
   45  not apply to a policy which covers persons employed  in  more  than  one
   46  state  or  the  benefit structure of which was the subject of collective
   47  bargaining affecting persons who are employed in more  than  one  state.
   48  Such coverage shall be at least equal to the following: (1) with respect
   49  to  benefits for detoxification as a consequence of chemical dependence,
   50  inpatient benefits for care in a hospital or detoxification facility may
   51  not be limited to less than seven days of active treatment in any calen-
   52  dar year; and (2) with respect to benefits for inpatient  rehabilitation
   53  services,  such  benefits may not be limited to less than thirty days of
   54  inpatient rehabilitation in a hospital based or free  standing  chemical
   55  dependence  facility  in  any  calendar  year.]  SUBSTANCE USE DISORDER,
   56  INCLUDING DETOXIFICATION AND REHABILITATION  SERVICES.    SUCH  COVERAGE
       S. 7912                             5                           A. 10164
    1  SHALL NOT APPLY FINANCIAL REQUIREMENTS OR TREATMENT LIMITATIONS TO INPA-
    2  TIENT SUBSTANCE USE DISORDER BENEFITS THAT ARE MORE RESTRICTIVE THAN THE
    3  PREDOMINANT  FINANCIAL REQUIREMENTS AND TREATMENT LIMITATIONS APPLIED TO
    4  SUBSTANTIALLY ALL MEDICAL AND SURGICAL BENEFITS COVERED BY THE CONTRACT.
    5  FURTHER,  SUCH  COVERAGE  SHALL  BE PROVIDED CONSISTENT WITH THE FEDERAL
    6  PAUL WELLSTONE AND PETE DOMENICI  MENTAL  HEALTH  PARITY  AND  ADDICTION
    7  EQUITY ACT OF 2008 (29 U.S.C. S 1185A).
    8    [Such  coverage]  (2)  COVERAGE  PROVIDED UNDER THIS SUBSECTION may be
    9  limited to facilities in New York  state  which  are  certified  by  the
   10  office  of alcoholism and substance abuse services and, in other states,
   11  to those which are accredited by the joint commission [on  accreditation
   12  of  hospitals]  as  alcoholism,  substance abuse, or chemical dependence
   13  treatment programs. [Such coverage shall be made available at the incep-
   14  tion of all new policies and with respect to policies issued before  the
   15  effective  date  of this subsection at the first annual anniversary date
   16  thereafter, without evidence of insurability and at any subsequent annu-
   17  al anniversary date subject to evidence of insurability.
   18    Such coverage] (3) COVERAGE PROVIDED  UNDER  THIS  SUBSECTION  may  be
   19  subject to annual deductibles and co-insurance as [may be] deemed appro-
   20  priate  by the superintendent and THAT are consistent with those imposed
   21  on other benefits within a given  [policy]  CONTRACT.    [Further,  each
   22  hospital  service corporation or health service corporation shall report
   23  to the superintendent each year the number of contract holders  to  whom
   24  it  has  issued policies for the inpatient treatment of chemical depend-
   25  ence, and the approximate number of persons covered  by  such  policies.
   26  Such coverage shall not replace, restrict or eliminate existing coverage
   27  provided  by  the  policy.  Written  notice  of the availability of such
   28  coverage shall be delivered  to  the  group  remitting  agent  or  group
   29  contract  holder prior to inception of such contract and annually there-
   30  after, except that this notice shall not  be  required  where  a  policy
   31  covers  two hundred or more employees or where the benefit structure was
   32  the subject of collective bargaining affecting persons who are  employed
   33  in more than one state.]
   34    (l)  [A  hospital  service corporation or a health service corporation
   35  which] (1) EVERY CONTRACT THAT  provides  [group,  group  remittance  or
   36  school  blanket  coverage  for  inpatient  hospital care] MEDICAL, MAJOR
   37  MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE must  provide  OUTPATIENT
   38  coverage for [at least sixty outpatient visits in any calendar year for]
   39  the diagnosis and treatment of [chemical dependence of which up to twen-
   40  ty may be for family members, except that this provision shall not apply
   41  to  a  contract  issued  pursuant to section four thousand three hundred
   42  five of this article which covers persons  employed  in  more  than  one
   43  state  or  the  benefit structure of which was the subject of collective
   44  bargaining affecting persons who are employed in more than  one  state.]
   45  SUBSTANCE  USE  DISORDER,  INCLUDING  DETOXIFICATION  AND REHABILITATION
   46  SERVICES.   SUCH COVERAGE SHALL  NOT  APPLY  FINANCIAL  REQUIREMENTS  OR
   47  TREATMENT LIMITATIONS TO OUTPATIENT SUBSTANCE USE DISORDER BENEFITS THAT
   48  ARE  MORE  RESTRICTIVE  THAN  THE PREDOMINANT FINANCIAL REQUIREMENTS AND
   49  TREATMENT LIMITATIONS APPLIED TO SUBSTANTIALLY ALL MEDICAL AND  SURGICAL
   50  BENEFITS  COVERED  BY  THE  CONTRACT.    FURTHER, SUCH COVERAGE SHALL BE
   51  PROVIDED CONSISTENT WITH THE FEDERAL PAUL WELLSTONE  AND  PETE  DOMENICI
   52  MENTAL  HEALTH  PARITY  AND  ADDICTION  EQUITY  ACT OF 2008 (29 U.S.C. S
   53  1185A).
   54    [Such coverage] (2) COVERAGE UNDER THIS SUBSECTION may be  limited  to
   55  facilities  in  New York state certified by the office of alcoholism and
   56  substance abuse services or licensed by such office as outpatient  clin-
       S. 7912                             6                           A. 10164
    1  ics  or medically supervised ambulatory substance abuse programs and, in
    2  other states, to those which are accredited by the joint commission  [on
    3  accreditation   of  hospitals]  as  alcoholism  or  chemical  dependence
    4  substance abuse treatment programs.
    5    [Such  coverage]  (3)  COVERAGE  PROVIDED UNDER THIS SUBSECTION may be
    6  subject to annual deductibles and co-insurance as [may be] deemed appro-
    7  priate by the superintendent and THAT are consistent with those  imposed
    8  on  other  benefits  within  a given [policy] CONTRACT.   [Such coverage
    9  shall not replace, restrict or eliminate existing coverage  provided  by
   10  the  policy.  Except  as  otherwise provided in the applicable policy or
   11  contract, no hospital service corporation or health service  corporation
   12  providing  coverage  for alcoholism or substance abuse services pursuant
   13  to this section shall deny coverage to a family member]
   14    (4) A CONTRACT PROVIDING COVERAGE FOR SUBSTANCE USE DISORDER  SERVICES
   15  PURSUANT TO THIS SUBSECTION SHALL PROVIDE UP TO TWENTY OUTPATIENT VISITS
   16  PER CONTRACT OR CALENDAR YEAR TO AN INDIVIDUAL who identifies [themself]
   17  HIM  OR  HERSELF  as  a  family  member  of a person suffering from [the
   18  disease of alcoholism, substance abuse or chemical dependency] SUBSTANCE
   19  USE DISORDER and who seeks treatment as a family member who is otherwise
   20  covered  by  the  applicable  [policy  or]  contract  pursuant  to  this
   21  [section]  SUBSECTION.    The coverage required by this subsection shall
   22  include treatment as a family member pursuant to such family  [members']
   23  MEMBER'S own [policy or] contract provided such family member:
   24    [(i)]  (A)  does  not  exceed  the  allowable  number of family visits
   25  provided by  the  applicable  [policy  or]  contract  pursuant  to  this
   26  [section,] SUBSECTION; and
   27    [(ii)]  (B)  is  otherwise  entitled  to  coverage  pursuant  to  this
   28  [section] SUBSECTION and  such  family  [members']  MEMBER'S  applicable
   29  [policy or] contract.
   30    S  3-a. Item (ii) of subparagraph (B) of paragraph 1 of subsection (b)
   31  of section 4900 of the insurance law, as amended by chapter 586  of  the
   32  laws  of 1998, is amended and a new subparagraph (C) is added to read as
   33  follows:
   34    (ii) is in the same profession and same or similar  specialty  as  the
   35  health  care  provider  who  typically  manages the medical condition or
   36  disease or provides the health care service or treatment  under  review;
   37  [and] OR
   38    (C)  FOR  PURPOSES OF A DETERMINATION INVOLVING SUBSTANCE USE DISORDER
   39  TREATMENT:
   40    (I) A PHYSICIAN WHO  POSSESSES  A  CURRENT  AND  VALID  NON-RESTRICTED
   41  LICENSE  TO  PRACTICE  MEDICINE AND WHO SPECIALIZES IN BEHAVIORAL HEALTH
   42  AND HAS EXPERIENCE IN THE DELIVERY OF SUBSTANCE USE DISORDER COURSES  OF
   43  TREATMENT; OR
   44    (II)  A  HEALTH  CARE PROFESSIONAL OTHER THAN A LICENSED PHYSICIAN WHO
   45  SPECIALIZES IN BEHAVIORAL HEALTH AND HAS EXPERIENCE IN THE  DELIVERY  OF
   46  SUBSTANCE  USE  DISORDER  COURSES  OF  TREATMENT  AND, WHERE APPLICABLE,
   47  POSSESSES A CURRENT AND VALID  NON-RESTRICTED  LICENSE,  CERTIFICATE  OR
   48  REGISTRATION OR, WHERE NO PROVISION FOR A LICENSE, CERTIFICATE OR REGIS-
   49  TRATION  EXISTS, IS CREDENTIALED BY THE NATIONAL ACCREDITING BODY APPRO-
   50  PRIATE TO THE PROFESSION; AND
   51    S 4. Subsection (a) of section 4902 of the insurance law is amended by
   52  adding a new paragraph 9 to read as follows:
   53    (9) WHEN CONDUCTING UTILIZATION REVIEW  FOR  PURPOSES  OF  DETERMINING
   54  HEALTH CARE COVERAGE FOR SUBSTANCE USE DISORDER TREATMENT, A UTILIZATION
   55  REVIEW  AGENT  SHALL UTILIZE RECOGNIZED EVIDENCE-BASED AND PEER REVIEWED
   56  CLINICAL REVIEW CRITERIA THAT IS APPROPRIATE TO THE AGE OF  THE  PATIENT
       S. 7912                             7                           A. 10164
    1  AND  IS DEEMED APPROPRIATE AND APPROVED FOR SUCH USE BY THE COMMISSIONER
    2  OF THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES IN CONSULTATION
    3  WITH THE COMMISSIONER OF HEALTH AND THE SUPERINTENDENT.
    4    THE  OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES IN CONSULTATION
    5  WITH THE COMMISSIONER OF HEALTH AND THE SUPERINTENDENT SHALL  APPROVE  A
    6  RECOGNIZED EVIDENCE-BASED AND PEER REVIEWED CLINICAL REVIEW CRITERIA, IN
    7  ADDITION TO ANY OTHER APPROVED EVIDENCE-BASED AND PEER REVIEWED CLINICAL
    8  REVIEW CRITERIA.
    9    S  5.  Subsection (c) of section 4903 of the insurance law, as amended
   10  by chapter 237 of the laws of 2009, is amended to read as follows:
   11    (c) (1) A utilization review agent shall make a determination  involv-
   12  ing  continued or extended health care services, additional services for
   13  an insured undergoing a course of continued treatment  prescribed  by  a
   14  health  care  provider, OR REQUESTS FOR INPATIENT SUBSTANCE USE DISORDER
   15  TREATMENT, or home health care services following an inpatient  hospital
   16  admission, and shall provide notice of such determination to the insured
   17  or  the  insured's  designee,  which  may  be satisfied by notice to the
   18  insured's health care provider, by telephone and in writing  within  one
   19  business  day  of  receipt  of  the  necessary  information except, with
   20  respect to home health care services  following  an  inpatient  hospital
   21  admission, within seventy-two hours of receipt of the necessary informa-
   22  tion  when the day subsequent to the request falls on a weekend or holi-
   23  day AND EXCEPT, WITH RESPECT TO INPATIENT SUBSTANCE USE DISORDER  TREAT-
   24  MENT,  WITHIN  TWENTY-FOUR  HOURS OF RECEIPT OF THE REQUEST FOR SERVICES
   25  WHEN THE REQUEST IS  SUBMITTED  AT  LEAST  TWENTY-FOUR  HOURS  PRIOR  TO
   26  DISCHARGE  FROM  AN  INPATIENT ADMISSION.   Notification of continued or
   27  extended  services  shall  include  the  number  of  extended   services
   28  approved,  the  new  total  of  approved  services, the date of onset of
   29  services and the next review date.
   30    (2) Provided that a request for home  health  care  services  and  all
   31  necessary information is submitted to the utilization review agent prior
   32  to  discharge  from  an  inpatient  hospital  admission pursuant to this
   33  subsection, a utilization review agent shall not deny, on the  basis  of
   34  medical  necessity  or  lack  of  prior authorization, coverage for home
   35  health care services while a determination  by  the  utilization  review
   36  agent is pending.
   37    (3)  PROVIDED THAT A REQUEST FOR INPATIENT TREATMENT FOR SUBSTANCE USE
   38  DISORDER  IS  SUBMITTED  TO  THE  UTILIZATION  REVIEW  AGENT  AT   LEAST
   39  TWENTY-FOUR  HOURS PRIOR TO DISCHARGE FROM AN INPATIENT ADMISSION PURSU-
   40  ANT TO THIS SUBSECTION, A UTILIZATION REVIEW AGENT SHALL  NOT  DENY,  ON
   41  THE  BASIS OF MEDICAL NECESSITY OR LACK OF PRIOR AUTHORIZATION, COVERAGE
   42  FOR THE INPATIENT SUBSTANCE USE DISORDER TREATMENT WHILE A DETERMINATION
   43  BY THE UTILIZATION REVIEW AGENT IS PENDING.
   44    S 6. Subsection (b) of section 4904 of the insurance law,  as  amended
   45  by chapter 237 of the laws of 2009, is amended to read as follows:
   46    (b)  A  utilization  review  agent shall establish an expedited appeal
   47  process for appeal of an adverse determination involving  (1)  continued
   48  or extended health care services, procedures or treatments or additional
   49  services  for  an  insured  undergoing  a  course of continued treatment
   50  prescribed by a health  care  provider  or  home  health  care  services
   51  following  discharge  from  an  inpatient hospital admission pursuant to
   52  subsection (c) of section four thousand nine hundred three of this arti-
   53  cle or (2) an adverse determination in which the  health  care  provider
   54  believes  an  immediate  appeal  is  warranted  except any retrospective
   55  determination. Such process shall include  mechanisms  which  facilitate
   56  resolution  of  the  appeal  including but not limited to the sharing of
       S. 7912                             8                           A. 10164
    1  information from the insured's health care provider and the  utilization
    2  review agent by telephonic means or by facsimile. The utilization review
    3  agent  shall  provide  reasonable  access  to its clinical peer reviewer
    4  within  one  business  day of receiving notice of the taking of an expe-
    5  dited appeal. Expedited appeals shall be determined within two  business
    6  days  of receipt of necessary information to conduct such appeal EXCEPT,
    7  WITH RESPECT TO INPATIENT  SUBSTANCE  USE  DISORDER  TREATMENT  PROVIDED
    8  PURSUANT  TO  PARAGRAPH THREE OF SUBSECTION (C) OF SECTION FOUR THOUSAND
    9  NINE HUNDRED THREE OF THIS ARTICLE, EXPEDITED APPEALS  SHALL  BE  DETER-
   10  MINED  WITHIN  TWENTY-FOUR  HOURS  OF RECEIPT OF SUCH APPEAL.  Expedited
   11  appeals which do not result in a resolution satisfactory to the  appeal-
   12  ing  party  may be further appealed through the standard appeal process,
   13  or through the external appeal process pursuant to section four thousand
   14  nine hundred fourteen of this article as applicable.  PROVIDED THAT  THE
   15  INSURED  OR THE INSURED'S HEALTH CARE PROVIDER FILES AN EXPEDITED INTER-
   16  NAL AND EXTERNAL APPEAL WITHIN TWENTY-FOUR  HOURS  FROM  RECEIPT  OF  AN
   17  ADVERSE DETERMINATION FOR INPATIENT SUBSTANCE USE DISORDER TREATMENT FOR
   18  WHICH  COVERAGE WAS PROVIDED WHILE THE INITIAL UTILIZATION REVIEW DETER-
   19  MINATION WAS PENDING PURSUANT TO PARAGRAPH THREE OF  SUBSECTION  (C)  OF
   20  SECTION  FOUR THOUSAND NINE HUNDRED THREE OF THIS ARTICLE, A UTILIZATION
   21  REVIEW AGENT SHALL NOT DENY ON THE BASIS OF MEDICAL NECESSITY OR LACK OF
   22  PRIOR AUTHORIZATION SUCH SUBSTANCE USE DISORDER TREATMENT WHILE A DETER-
   23  MINATION BY THE UTILIZATION REVIEW AGENT OR  EXTERNAL  APPEAL  AGENT  IS
   24  PENDING.
   25    S  6-a. Item (B) of subparagraph (i) of paragraph (a) of subdivision 2
   26  of section 4900 of the public health law, as amended by chapter  586  of
   27  the  laws  of  1998, is amended and a new subparagraph (iii) is added to
   28  read as follows:
   29    (B) is in the same profession and same or  similar  specialty  as  the
   30  health  care  provider  who  typically  manages the medical condition or
   31  disease or provides the health care service or treatment  under  review;
   32  [and] OR
   33    (III) FOR PURPOSES OF A DETERMINATION INVOLVING SUBSTANCE USE DISORDER
   34  TREATMENT:
   35    (A)  A  PHYSICIAN  WHO  POSSESSES  A  CURRENT AND VALID NON-RESTRICTED
   36  LICENSE TO PRACTICE MEDICINE AND WHO SPECIALIZES  IN  BEHAVIORAL  HEALTH
   37  AND  HAS EXPERIENCE IN THE DELIVERY OF SUBSTANCE USE DISORDER COURSES OF
   38  TREATMENT; OR
   39    (B) A HEALTH CARE PROFESSIONAL OTHER THAN  A  LICENSED  PHYSICIAN  WHO
   40  SPECIALIZES  IN  BEHAVIORAL HEALTH AND HAS EXPERIENCE IN THE DELIVERY OF
   41  SUBSTANCE USE DISORDER  COURSES  OF  TREATMENT  AND,  WHERE  APPLICABLE,
   42  POSSESSES  A  CURRENT  AND  VALID NON-RESTRICTED LICENSE, CERTIFICATE OR
   43  REGISTRATION OR, WHERE NO PROVISION FOR A LICENSE, CERTIFICATE OR REGIS-
   44  TRATION EXISTS, IS CREDENTIALED BY THE NATIONAL ACCREDITING BODY  APPRO-
   45  PRIATE TO THE PROFESSION; AND
   46    S 7. Subdivision 1 of section 4902 of the public health law is amended
   47  by adding a new paragraph (i) to read as follows:
   48    (I)  WHEN  CONDUCTING  UTILIZATION  REVIEW FOR PURPOSES OF DETERMINING
   49  HEALTH CARE COVERAGE FOR SUBSTANCE USE DISORDER TREATMENT, A UTILIZATION
   50  REVIEW AGENT SHALL UTILIZE RECOGNIZED EVIDENCE-BASED AND  PEER  REVIEWED
   51  CLINICAL  REVIEW  CRITERIA THAT IS APPROPRIATE TO THE AGE OF THE PATIENT
   52  AND IS DEEMED APPROPRIATE AND APPROVED FOR SUCH USE BY THE  COMMISSIONER
   53  OF THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES IN CONSULTATION
   54  WITH THE COMMISSIONER AND THE SUPERINTENDENT OF FINANCIAL SERVICES.
   55    THE  OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES IN CONSULTATION
   56  WITH THE COMMISSIONER AND THE SUPERINTENDENT OF FINANCIAL SERVICES SHALL
       S. 7912                             9                           A. 10164
    1  APPROVE A RECOGNIZED EVIDENCE-BASED AND PEER  REVIEWED  CLINICAL  REVIEW
    2  CRITERIA,  IN  ADDITION  TO  ANY  OTHER APPROVED EVIDENCE-BASED AND PEER
    3  REVIEWED CLINICAL REVIEW CRITERIA.
    4    S  8.  Subdivision  3  of  section  4903  of the public health law, as
    5  amended by chapter 237 of the laws  of  2009,  is  amended  to  read  as
    6  follows:
    7    3. (A) A utilization review agent shall make a determination involving
    8  continued  or  extended health care services, additional services for an
    9  enrollee undergoing a course of  continued  treatment  prescribed  by  a
   10  health  care  provider, OR REQUESTS FOR INPATIENT SUBSTANCE USE DISORDER
   11  TREATMENT, or home health care services following an inpatient  hospital
   12  admission,  and shall provide notice of such determination to the enrol-
   13  lee or the enrollee's designee, which may be satisfied by notice to  the
   14  enrollee's  health care provider, by telephone and in writing within one
   15  business day of  receipt  of  the  necessary  information  except,  with
   16  respect  to  home  health  care services following an inpatient hospital
   17  admission, within seventy-two hours of receipt of the necessary informa-
   18  tion when the day subsequent to the request falls on a weekend or  holi-
   19  day  AND EXCEPT, WITH RESPECT TO INPATIENT SUBSTANCE USE DISORDER TREAT-
   20  MENT, WITHIN TWENTY-FOUR HOURS OF RECEIPT OF THE  REQUEST  FOR  SERVICES
   21  WHEN  THE  REQUEST  IS  SUBMITTED  AT  LEAST  TWENTY-FOUR HOURS PRIOR TO
   22  DISCHARGE FROM AN INPATIENT  ADMISSION.  Notification  of  continued  or
   23  extended   services  shall  include  the  number  of  extended  services
   24  approved, the new total of approved  services,  the  date  of  onset  of
   25  services and the next review date.
   26    (B)  Provided  that  a  request  for home health care services and all
   27  necessary information is submitted to the utilization review agent prior
   28  to discharge from an  inpatient  hospital  admission  pursuant  to  this
   29  subdivision,  a utilization review agent shall not deny, on the basis of
   30  medical necessity or lack of  prior  authorization,  coverage  for  home
   31  health  care  services  while  a determination by the utilization review
   32  agent is pending.
   33    (C) PROVIDED THAT A REQUEST FOR INPATIENT TREATMENT FOR SUBSTANCE  USE
   34  DISORDER   IS  SUBMITTED  TO  THE  UTILIZATION  REVIEW  AGENT  AT  LEAST
   35  TWENTY-FOUR HOURS PRIOR TO DISCHARGE FROM AN INPATIENT ADMISSION  PURSU-
   36  ANT  TO  THIS SUBDIVISION, A UTILIZATION REVIEW AGENT SHALL NOT DENY, ON
   37  THE BASIS OF MEDICAL NECESSITY OR LACK OF PRIOR AUTHORIZATION,  COVERAGE
   38  FOR THE INPATIENT SUBSTANCE USE DISORDER TREATMENT WHILE A DETERMINATION
   39  BY THE UTILIZATION REVIEW AGENT IS PENDING.
   40    S  9.  Subdivision  2  of  section  4904  of the public health law, as
   41  amended by chapter 237 of the laws  of  2009,  is  amended  to  read  as
   42  follows:
   43    2.  A  utilization  review  agent  shall establish an expedited appeal
   44  process for appeal of an adverse determination involving:
   45    (a) continued or extended health care services, procedures  or  treat-
   46  ments  or  additional  services  for  an enrollee undergoing a course of
   47  continued treatment prescribed by a health  care  provider  home  health
   48  care  services  following discharge from an inpatient hospital admission
   49  pursuant to subdivision three of section  forty-nine  hundred  three  of
   50  this article; or
   51    (b)  an  adverse  determination  in  which  the  health  care provider
   52  believes an immediate  appeal  is  warranted  except  any  retrospective
   53  determination.    Such process shall include mechanisms which facilitate
   54  resolution of the appeal including but not limited  to  the  sharing  of
   55  information from the enrollee's health care provider and the utilization
   56  review agent by telephonic means or by facsimile. The utilization review
       S. 7912                            10                           A. 10164
    1  agent  shall  provide  reasonable  access  to its clinical peer reviewer
    2  within one business day of receiving notice of the taking  of  an  expe-
    3  dited appeal.  Expedited appeals shall be determined within two business
    4  days  of receipt of necessary information to conduct such appeal EXCEPT,
    5  WITH RESPECT TO INPATIENT  SUBSTANCE  USE  DISORDER  TREATMENT  PROVIDED
    6  PURSUANT TO PARAGRAPH (C) OF SUBDIVISION 3 OF SECTION FOUR THOUSAND NINE
    7  HUNDRED  THREE  OF  THIS  ARTICLE, EXPEDITED APPEALS SHALL BE DETERMINED
    8  WITHIN TWENTY-FOUR HOURS OF RECEIPT OF SUCH  APPEAL.  Expedited  appeals
    9  which  do not result in a resolution satisfactory to the appealing party
   10  may be further appealed through the standard appeal process, or  through
   11  the external appeal process pursuant to section forty-nine hundred four-
   12  teen  of  this article as applicable.  PROVIDED THAT THE ENROLLEE OR THE
   13  ENROLLEE'S HEALTH CARE PROVIDER FILES AN EXPEDITED INTERNAL AND EXTERNAL
   14  APPEAL WITHIN TWENTY-FOUR HOURS FROM RECEIPT OF AN ADVERSE DETERMINATION
   15  FOR INPATIENT SUBSTANCE USE DISORDER TREATMENT FOR  WHICH  COVERAGE  WAS
   16  PROVIDED  WHILE THE INITIAL UTILIZATION REVIEW DETERMINATION WAS PENDING
   17  PURSUANT TO PARAGRAPH (C) OF SUBDIVISION 3 OF SECTION FOUR THOUSAND NINE
   18  HUNDRED THREE OF THIS ARTICLE, A UTILIZATION REVIEW AGENT SHALL NOT DENY
   19  ON THE BASIS OF MEDICAL NECESSITY OR LACK OF  PRIOR  AUTHORIZATION  SUCH
   20  SUBSTANCE  USE  DISORDER TREATMENT WHILE A DETERMINATION BY THE UTILIZA-
   21  TION REVIEW AGENT OR EXTERNAL APPEAL AGENT IS PENDING.
   22    S 10. Section 309 of the insurance law is  amended  by  adding  a  new
   23  subsection (c) to read as follows:
   24    (C)  AS PART OF AN EXAMINATION, THE SUPERINTENDENT SHALL REVIEW DETER-
   25  MINATIONS OF COVERAGE FOR SUBSTANCE USE  DISORDER  TREATMENT  AND  SHALL
   26  ENSURE  THAT  SUCH DETERMINATIONS ARE ISSUED IN COMPLIANCE WITH SECTIONS
   27  THREE  THOUSAND  TWO  HUNDRED  SIXTEEN,  THREE  THOUSAND   TWO   HUNDRED
   28  TWENTY-ONE,  FOUR THOUSAND THREE HUNDRED THREE, AND TITLE ONE OF ARTICLE
   29  FORTY-NINE OF THIS CHAPTER.
   30    S 10-a. Subdivision 2 of section 4409 of the  public  health  law,  as
   31  amended  by  chapter  805  of  the  laws  of 1984, is amended to read as
   32  follows:
   33    2. The superintendent shall examine not less  than  once  every  three
   34  years  into  the  financial affairs of each health maintenance organiza-
   35  tion, and transmit his findings to the commissioner. In connection  with
   36  any such examination, the superintendent shall have convenient access at
   37  all  reasonable  hours  to all books, records, files and other documents
   38  relating to the affairs of such organization, which are relevant to  the
   39  examination.  The  superintendent  may  exercise the powers set forth in
   40  sections three hundred four, three hundred five, three hundred  six  and
   41  three  hundred ten of the insurance law in connection with such examina-
   42  tions, and may also require special reports from such health maintenance
   43  organizations as specified in section three hundred eight of the  insur-
   44  ance  law.    AS PART OF AN EXAMINATION, THE SUPERINTENDENT SHALL REVIEW
   45  DETERMINATIONS OF COVERAGE FOR  SUBSTANCE  USE  DISORDER  TREATMENT  AND
   46  SHALL  ENSURE  THAT  SUCH  DETERMINATIONS  ARE ISSUED IN COMPLIANCE WITH
   47  SECTION FOUR THOUSAND THREE HUNDRED THREE OF THE INSURANCE LAW AND TITLE
   48  ONE OF ARTICLE FORTY-NINE OF THIS CHAPTER.
   49    S 11. 1. Within thirty days of the effective date  of  this  act,  the
   50  commissioner  of  the office of alcoholism and substance abuse services,
   51  superintendent of the department of financial services, and the  commis-
   52  sioner  of  health,  shall jointly convene a workgroup to study and make
   53  recommendations on improving access to and availability of substance use
   54  disorder treatment  services  in  the  state.  The  workgroup  shall  be
   55  co-chaired  by  such  commissioners  and  superintendent, and shall also
   56  include, but not be limited to, representatives of health  care  provid-
       S. 7912                            11                           A. 10164
    1  ers,  insurers,  additional  professionals, individuals and families who
    2  have been affected by addiction. The workgroup shall include, but not be
    3  limited to, a review of the following:
    4    a.  Identifying barriers to obtaining necessary substance use disorder
    5  treatment services for across the state;
    6    b. Recommendations  for  increasing  access  to  and  availability  of
    7  substance use disorder treatment services in the state, including under-
    8  served areas of the state;
    9    c.  Identifying  best  clinical  practices  for substance use disorder
   10  treatment services;
   11    d. A review of current insurance coverage requirements and recommenda-
   12  tions for improving insurance coverage for substance use disorder treat-
   13  ment;
   14    e.  Recommendations  for  improving  state  agency  communication  and
   15  collaboration  relating  to substance use disorder treatment services in
   16  the state;
   17    f. Resources for affected individuals  and  families  who  are  having
   18  difficulties   obtaining  necessary  substance  use  disorder  treatment
   19  services; and
   20    g. Methods for developing quality standards to measure the performance
   21  of substance use disorder treatment facilities in the state.
   22    2. The workgroup shall submit a report of its findings and recommenda-
   23  tions to the governor, the temporary president of the senate, the speak-
   24  er of the assembly, the chairs of  the  senate  and  assembly  insurance
   25  committees,  and the chairs of the senate and assembly health committees
   26  no later than December 31, 2015.
   27    S 12. This act shall take effect immediately; provided,  however  that
   28  sections  one, two, three, three-a, four, five, six, six-a, seven, eight
   29  and nine of this act shall take effect April 1, 2015 and shall apply  to
   30  policies  and contracts issued, renewed, modified, altered or amended on
   31  and after such date.
feedback